BPC-157 Colombia - Complete Research Dosing & Recovery Guide

Important: BPC-157 is an experimental research peptide. The information below is for educational purposes only and is not medical advice. BPC-157 is not approved for human use.

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein fragment. It has been widely explored in preclinical research for tissue recovery, vascular support, and inflammation pathways. Human data remain limited.

Quick Facts

CAS	137525-51-0
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Formula / MW	C₆₂H₉₈N₁₆O₂₂ · ~1419.5 g/mol
Appearance	White lyophilized powder
Storage (powder)	–20 °C (long-term)
Storage (reconstituted)	2–8 °C; avoid repeated freeze–thaw

How Does It Work? (Research Context)

Angiogenesis & circulation: explored for supporting new blood vessel growth and tissue perfusion.
Inflammation pathways: literature describes modulation of pro-/anti-inflammatory signals.
Tissue repair models: animal studies report improved outcomes in tendon, ligament, muscle, bone, and GI mucosa.

Note: Findings above are from preclinical research; human evidence is sparse (e.g., a small pilot safety infusion).

What Research Has Explored

Musculoskeletal recovery models (muscle, tendon, ligament, bone)
Gastrointestinal mucosal protection and healing
Vascular remodeling and nitric-oxide–related signaling

Regulatory Notes (Athletes & Safety)

WADA: BPC-157 is listed under S0: Non-approved substances on the World Anti-Doping Agency Prohibited List.
FDA (US): BPC-157 appears on the Category 2 bulks list for compounding, citing limited safety data and impurity/characterization risks.

Safety & Side Effects

Human safety data are limited. Reported effects in anecdotal contexts include digestive upset or headache; robust clinical profiles are lacking. Treat strictly as a research-only material. Athletes should avoid due to WADA status.

Interesting Notes & Practical Tips

Oral activity? Some animal studies suggest BPC-157 may remain stable when taken orally, unusual for a peptide. This comes from its origin in gastric proteins, though human data is very limited.
Nitric oxide link: Research connects BPC-157 to the NO pathway, with effects on blood pressure and circulation. This has made it popular in vascular recovery studies.
Quality check: After mixing, your solution should be clear and colorless. Persistent cloudiness or flakes are red flags for poor quality.
Popular pair: Often studied alongside TB-500 for “healing stacks.” Researchers note potential synergy between the two peptides.
Global paradox: Even though BPC-157 is banned for athletes and flagged by regulators, it remains one of the most purchased peptides worldwide for recovery research.

Lifestyle Tips (General Research Context)

For recovery-focused projects, basic habits matter: stay well-hydrated, aim for adequate protein, keep regular resistance + light cardio sessions, and maintain 7–8 hours of sleep. These habits consistently support metabolic and tissue-repair goals in research settings.

Reconstitution Guide (10 mg Vial)

Add 2 mL bacteriostatic water to your 10 mg vial.
Final concentration = 5 mg/mL (i.e., 1 mL = 5 mg).
On a 100-unit insulin syringe: 1 mL = 100 units.

Amount	Volume (mL)	Syringe (units)
250 mcg (0.25 mg)	0.05 mL	5 units
500 mcg (0.5 mg)	0.10 mL	10 units
1 mg	0.20 mL	20 units
2 mg	0.40 mL	40 units

After mixing, store at 2–8 °C and use within 20–30 days. Keep powder at –20 °C long-term. Do not refreeze after reconstitution.

Example Research Dosing Planning

Principle: start low and increase gradually, allowing time at each level to assess tolerance.

Common lab planning uses small per-administration totals (e.g., 250–500 mcg), adjusted stepwise.
Preclinical rodent models often use weight-based microgram dosing across 10–14 days; translate cautiously across species.

All values above are research context examples, not medical guidance.